版本:
中国

BRIEF-Biomarin says Brineura U.S. annual price $486,000

April 27 Biomarin Pharmaceutical Inc

* Biomarin Pharmaceuticals says expects to begin shipping just approved Brineura within 6 weeks

* Biomarin says expected annual cost for Brineura to be $486,000 for ultra-rare pediatric brain disease

* Biomarin says will have co-pay program to assist with out-of-pocket cost of brineura Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐